We are live on ! Find out more
IIM

Ipswich Investment Management Portfolio holdings

AUM $474M
1-Year Est. Return 35.58%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+35.58%
3 Year Est. Return
+92.81%
5 Year Est. Return
+126.14%
10 Year Est. Return
+1,334%
AUM
$218M
AUM Growth
-$19.5M
Cap. Flow
-$26.1M
Cap. Flow %
-12.01%
Top 10 Hldgs %
34.99%
Holding
155
New
4
Increased
43
Reduced
29
Closed
73

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$3.49M
2
XOM icon
ExxonMobil
XOM
+$2.58M
3
ABBV icon
AbbVie
ABBV
+$2.54M
4
JPM icon
JPMorgan Chase
JPM
+$2.17M
5
UNP icon
Union Pacific
UNP
+$2.03M

Sector Composition

Rank Sector Weight
1 Healthcare 17.52%
2 Technology 17.25%
3 Energy 15.36%
4 Industrials 13.57%
5 Financials 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
26
Merck
MRK
$323B
$3.16M 1.45%
54,621
+3,985
+8% +$225K
BAX icon
27
Baxter International
BAX
$14.4B
$2.8M 1.29%
37,872
-34,845
-48% -$2.46M
GSK icon
28
GSK
GSK
$104B
$2.79M 1.28%
55,348
+37,656
+213% +$1.9M
ABBV icon
29
AbbVie
ABBV
$438B
$2.77M 1.28%
29,955
+26,055
+668% +$2.54M
ACN icon
30
Accenture
ACN
$109B
$2.77M 1.27%
16,935
+1,845
+12% +$287K
SLB icon
31
SLB Ltd
SLB
$78.9B
$2.64M 1.21%
39,386
-5,540
-12% -$380K
MRSH
32
Marsh
MRSH
$91B
$2.52M 1.16%
30,785
+1,630
+6% +$133K
CHD icon
33
Church & Dwight Co
CHD
$24.5B
$2.46M 1.13%
46,241
-959
-2% -$46.4K
PX
34
DELISTED
Praxair Inc
PX
$2.42M 1.11%
15,293
+95
+0.6% +$14.7K
LH icon
35
Labcorp
LH
$26.1B
$2.38M 1.1%
15,460
-1,735
-10% -$262K
PEP icon
36
PepsiCo
PEP
$188B
$2.37M 1.09%
21,764
+3,162
+17% +$327K
BNS icon
37
Scotiabank
BNS
$108B
$2.27M 1.04%
39,655
-6,986
-15% -$421K
RGNX icon
38
Regenxbio
RGNX
$688M
$2.24M 1.03%
31,271
+9,386
+43% +$448K
DUK icon
39
Duke Energy
DUK
$94.5B
$2.23M 1.03%
28,228
+909
+3% +$69.9K
DD icon
40
DuPont de Nemours
DD
$19.1B
$2.22M 1.02%
13,290
+9,100
+217% +$1.52M
EMR icon
41
Emerson Electric
EMR
$88.5B
$2.14M 0.98%
30,925
+12,600
+69% +$886K
TFC icon
42
Truist Financial
TFC
$63.4B
$2.11M 0.97%
41,781
-2,485
-6% -$132K
ABT icon
43
Abbott
ABT
$188B
$1.96M 0.9%
32,125
+28,725
+845% +$1.74M
CL icon
44
Colgate-Palmolive
CL
$74.3B
$1.93M 0.89%
29,832
-249
-0.8% -$16.3K
IBM icon
45
IBM
IBM
$223B
$1.93M 0.89%
14,466
+6,851
+90% +$955K
NVS icon
46
Novartis
NVS
$298B
$1.91M 0.88%
28,268
+1,674
+6% +$116K
GE icon
47
GE Aerospace
GE
$380B
$1.91M 0.88%
29,234
+8,078
+38% +$539K
MCD icon
48
McDonald's
MCD
$194B
$1.73M 0.8%
11,052
+1,070
+11% +$173K
AKAM icon
49
Akamai
AKAM
$16.9B
$1.64M 0.75%
22,427
+125
+0.6% +$9.38K
KO icon
50
Coca-Cola
KO
$374B
$1.59M 0.73%
36,305
+240
+0.7% +$10.4K

Similar funds

Ipswich Investment Management's Q2 2018 Portfolio in Review

As of Q2 2018, Ipswich Investment Management held 155 positions worth $218M, down 8.2% from $237M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ipswich Investment Management withdrew a net $26.1M in Q2 2018, closing 73 positions and reducing 29 holdings. Its most notable exit was Amazon, an estimated $5.53M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Technology and Energy.

Against the trend, Ipswich Investment Management opened a new position in Portola Pharmaceuticals, Inc. worth $1.17M.

  • Ipswich Investment Management's largest Q2 2018 buy was Portola Pharmaceuticals, Inc.: 31,040 shares worth $1.17M.
  • Ipswich Investment Management added most to 3M in Q2 2018, an estimated $3.49M increase.
  • Ipswich Investment Management's biggest Q2 2018 reduction was Baxter International, cutting an estimated $2.46M.
  • Ipswich Investment Management fully exited Amazon in Q2 2018, selling an estimated $5.53M.
  • Ipswich Investment Management's ten largest holdings make up 35% of its $218M portfolio in Q2 2018.
  • Ipswich Investment Management opened 4 new positions and closed 73 in Q2 2018.
  • Ipswich Investment Management's portfolio value fell 8.2% quarter-over-quarter to $218M.

Based on Ipswich Investment Management's 13F filing for Q2 2018, filed 18 Jul 2018.